Tools

U.S. Food and Drug Administration staff said on Tuesday they were wary about the benefits versus the risks of AstraZeneca… »   

An oral immunotherapy aimed at grass and pollen allergies has a benefit and safety profile that supports its approval, according… »   

U.S. Food and Drug Administration staff reviewing data on Boston Scientific Corp’s novel anti-stroke device highlighted the implant’s failure to… »   

Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from… »   

The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults… »   

Shares of OncoMed Pharmaceuticals Inc more than doubled on Tuesday after the biotechnology company said Celgene Corp would help it… »   

Denmark’s Novo Nordisk has a stronger development pipeline of new drug candidates than it has ever had before, and thinks… »   

An improved version of Sanofi’s diabetes drug Lantus is better than the old one at controlling blood sugar levels and… »   

A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies… »   

Researchers have identified the protein in malaria-causing Plasmodium parasites that is inhibited by a newly discovered class of anti-malarial… »